MSRA

Across TCGA pan-cancer cohorts, MSRA Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MSRA data layer compared with 27 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MSRA Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MSRA expression acts as an unfavorable survival marker.

COAD and KIRP are the cancer types where MSRA Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.223	0.691	.011	9	view →
KIRP	DFS	Median	All	0.218	0.771	.029	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MSRA–COAD (DFS)

Open the COAD breakdown →